Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is elevated homocysteine a marker of reduced methylation capacity?

Elevated homocysteine is a well-established functional indicator of impaired one-carbon metabolism and reduced cellular methylation capacity.

SupportedJune 19, 202610 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Elevated homocysteine is a functional marker of reduced methylation capacity within one-carbon metabolism.

laying out figure…
0 of 1 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim states that higher homocysteine reflects a disruption in one-carbon metabolism that lowers the SAM:SAH methylation index. Mechanistically, elevated homocysteine drives accumulation of SAH, which competitively inhibits methyltransferases and thereby reduces DNA, RNA, protein, and lipid methylation. This relationship makes plasma homocysteine a usable surrogate for impaired methylation flux in clinical and metabolic contexts.

Verified conclusion

Elevated homocysteine is a well-established functional indicator of impaired one-carbon metabolism and reduced methylation capacity. This relationship is particularly relevant for maintaining cellular processes like DNA synthesis and epigenetic regulation.

Clinical and metabolic evidence

Human observational studies consistently demonstrate that elevated plasma homocysteine correlates with global DNA hypomethylation. Research involving various patient populations shows that as homocysteine levels rise, the capacity for critical methylation reactions declines.

  • In patients with chronic conditions like hypertension or celiac disease, elevated homocysteine levels have been significantly associated with decreased global DNA methylation (p < 0.05).
  • Clinical data indicates a strong positive correlation (r = 0.81) between plasma homocysteine and cellular levels of S-adenosylhomocysteine (SAH), an inhibitor of methylation.
  • Studies have shown that homocysteine levels inversely correlate with DNA methylation status (r = 0.74), confirming its utility as a surrogate marker for methylation flux.

Mechanistic explanations

The role of homocysteine as a marker of methylation capacity is driven by the biochemistry of the methionine cycle.

  • The SAM:SAH Ratio: Methylation depends on the ratio of S-adenosylmethionine (SAM), the primary methyl donor, to S-adenosylhomocysteine (SAH). High homocysteine levels shift the equilibrium of the S-adenosylhomocysteinase (AHCY) reaction, leading to an accumulation of SAH.
  • Competitive Inhibition: SAH acts as a potent competitive inhibitor of methyltransferase enzymes. When homocysteine is elevated, the resulting increase in SAH lowers the "methylation index" (SAM:SAH ratio), effectively blocking the transfer of methyl groups to DNA, RNA, proteins, and lipids.
  • One-Carbon Integration: Homocysteine serves as a metabolic crossroads. Its elevation typically reflects a "bottleneck" in the folate or methionine cycles, often due to deficiencies in B-vitamins (B12, folate, B6) or genetic polymorphisms (such as MTHFR), which are essential for regenerating methionine from homocysteine.

Bottom line

Elevated homocysteine is a scientifically supported functional marker for reduced methylation capacity. It reflects an underlying disruption in one-carbon metabolism that leads to the accumulation of S-adenosylhomocysteine, which inhibits the methyltransferases required for vital cellular functions.

References

  1. Folate network genetic variation, plasma homocysteine, and global genomic methylation content: a genetic association study — pmc.ncbi.nlm.nih.gov ↗
  2. Homocysteine-methionine cycle is a metabolic sensor system controlling methylation-regulated pathological signaling — pmc.ncbi.nlm.nih.gov ↗
  3. Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism. — pmc.ncbi.nlm.nih.gov ↗
  4. DNA methylation as a biomarker for cardiometabolic disease risk — academic.oup.com ↗
  5. Determination of S-Adenosylmethionine and S-Adenosylhomocysteine by LC–MS/MS and evaluation of their stability in mice tissues — pmc.ncbi.nlm.nih.gov ↗
  6. Effects of Folio Acid Supplementation on Plasma Homocysteine and Thiobarbituric Acid Reactive Substances (TBARS) Levels and Liver SAM/SAH Ratio in Hyperhomocysteinaemia-induced Pregnant Rats — semanticscholar.org ↗
  7. Evaluation of global DNA methylation, homocysteine and vitamin B12 levels among patients with celiac disease — gastro-journal.com ↗
  8. Increase in Plasma Homocysteine Associated with Parallel Increases in Plasma S-Adenosylhomocysteine and Lymphocyte DNA Hypomethylation* — jbc.org ↗
  9. Blood biomarker levels of methylation capacity in autism spectrum disorder: a systematic review and meta‐analysis — onlinelibrary.wiley.com ↗
  10. AHCY: A metabolic gatekeeper at the interface of methylation, redox balance, and cellular stress response — linkinghub.elsevier.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→